INDACONITINE
- CAS NO.:4491-19-4
- Empirical Formula: C34H47NO10
- Molecular Weight: 629.74
- MDL number: MFCD01673508
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-07-16 07:06:08
What is INDACONITINE?
The Uses of INDACONITINE
Indaconitine is used in preparation of aconine and pseudaconine, their NMR spectra, and effect of solvents on conformation as reactant/reagent.
Definition
ChEBI: Indaconitine is a diterpenoid.
Properties of INDACONITINE
| Melting point: | 193-195℃ |
| Boiling point: | 666.59°C (rough estimate) |
| alpha | D21 +18.28° (c = 2.18 in alc) |
| Density | 1.33 |
| refractive index | 1.5960 (estimate) |
| solubility | Chloroform (Slightly) |
| form | Solid |
| pka | 12.82±0.70(Predicted) |
| color | Pale Beige |
Safety information for INDACONITINE
Computed Descriptors for INDACONITINE
New Products
2-(2-Chlorophenyl)glycine Propiolic Acid 1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene (±)-amino(2-fluorophenyl)acetic acid trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 1-Pentadecanol 4-(4-Αminophenyl)-3-Morpholinone 3-Morpholino-1-(4-(2-oxopiperidin-1-yl) phenyl)-5,6-dihyropyridin-2-(1H)-one 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one N-cyanoacetylurethane 1H-IndazoleRelated products of tetrahydrofuran








You may like
-
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
471-25-0 Propiolic Acid 98+View Details
471-25-0 -
84145-28-8 98+View Details
84145-28-8 -
trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+View Details
63909-29-5 -
2-(2-Chlorophenyl)glycine 88744-36-9 98+View Details
88744-36-9 -
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
629-76-5 98+View Details
629-76-5 -
1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+View Details
39816-35-8
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
